Aura (AURA) AI Stock Analysis

• Market Cap: ₪5.60B
• Dividend Yield: 0.66%
• Average Volume (3M): 582.98K
• Price to Earnings (P/E): 14.5
• Beta (1Y): 1.82
• Revenue Growth: 31.05%
• EPS Growth: -6.52%
• Country: IL
• Employees: 141
• Sector: Financial
• Sector Strength: 70
• Industry: Real Estate - Services
• EPS (TTM): 35.20
• Shares Outstanding: 285,706,630
• 10 Day Avg. Volume: 661,914
• 30 Day Avg. Volume: 582,982
• PEG Ratio: -0.88
• Price to Book (P/B): 3.58
• Price to Sales (P/S): 3.03
• P/FCF Ratio: -6.24
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 48 Neutral
• Price Target: 1,940.00 ▼(-12.73% Downside)
• Action: Reiterated Date: 03/27/26
• Date: Action: Reiterated 03/27/26

The score is held back primarily by weak cash flow and higher leverage, which raise financial risk despite solid revenue growth and operating profitability. Technicals also point to a sustained downtrend (below major moving averages with negative MACD). Valuation is only moderately supportive given a ~25.9 P/E and a low dividend yield.

Positive Factors

Durable Revenue Growth

Sustained top-line scaling over multiple years shows durable demand or successful portfolio expansion. A near-doubling of revenue in two years supports capacity to invest in operations, repay liabilities over time, and fund strategic initiatives without relying solely on short-term financing.

Negative Factors

Rising Leverage

Rapid debt accumulation reduces financial flexibility and raises refinancing and interest-rate exposure. Elevated leverage limits ability to absorb shocks, raises default risk if cash flows falter, and can force asset sales or equity raises that dilute holders over the medium term.

Aura Business Overview & Revenue Model

Company Description

Aura Investments Ltd. engages in the planning and establishing of real estate projects in Israel. It builds residential projects; and develops urban renewal projects. The company was incorporated in 1992 and is headquartered in Tel Aviv, Israel....

How the Company Makes Money

As a clinical-stage biotechnology company, Aura Biosciences does not have publicly disclosed recurring product revenue from commercialized drugs. Its operations have historically been funded primarily through financing activities such as the issua...

Read more

As a clinical-stage biotechnology company, Aura Biosciences does not have publicly disclosed recurring product revenue from commercialized drugs. Its operations have historically been funded primarily through financing activities such as the issua...

Aura Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.90B	1.52B	1.04B	849.01M	893.89M
Gross Profit	486.15M	347.51M	190.98M	139.44M	137.10M
EBITDA	589.25M	477.33M	208.47M	205.55M	182.64M
Net Income	280.75M	360.14M	117.69M	140.54M	113.53M
Balance Sheet
Total Assets	7.87B	4.88B	3.14B	2.60B	1.86B
Cash, Cash Equivalents and Short-Term Investments	663.97M	137.03M	129.36M	73.21M	67.45M
Total Debt	3.32B	2.26B	1.36B	845.63M	828.08M
Total Liabilities	6.00B	3.59B	2.24B	1.93B	1.34B
Stockholders Equity	1.61B	1.27B	882.03M	652.64M	520.38M
Cash Flow
Free Cash Flow	-925.57M	-127.40M	-565.56M	163.03M	207.27M
Operating Cash Flow	-921.50M	-122.29M	-564.73M	167.92M	207.99M
Investing Cash Flow	170.56M	-412.89M	-5.13M	-141.69M	-56.88M
Financing Cash Flow	972.09M	540.60M	607.07M	-26.42M	-194.34M

Aura Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2223.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:AURA, the sentiment is Negative. The current price of 2223 is above the 20-day moving average (MA) of 2065.55, above the 50-day MA of 2171.63, and above the 200-day MA of 2203.59, indicating a bearish trend. The MACD of -81.87 indicates Positive momentum. The RSI at 42.33 is Neutral, neither overbought nor oversold. The STOCH value of 29.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:AURA.

Aura Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
AFPR	64 Neutral	₪9.22B	9.71	―	―	―	―
MVNE	60 Neutral	₪9.42B	16.38	―	1.10%	11.13%	110.98%
AURA	48 Neutral	₪5.60B	14.47	―	0.66%	31.05%	-6.52%
ALHE	41 Neutral	₪7.78B	1,136.07	―	2.42%	6.64%	―